These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20191188)

  • 21. Infliximab for hidradenitis suppurativa.
    Sullivan TP; Welsh E; Kerdel FA; Burdick AE; Kirsner RS
    Br J Dermatol; 2003 Nov; 149(5):1046-9. PubMed ID: 14632813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New-onset polyarthritis during successful treatment of hidradenitis suppurativa with infliximab.
    van Rappard DC; Mooij JE; Baeten DL; Mekkes JR
    Br J Dermatol; 2011 Jul; 165(1):194-8. PubMed ID: 21428974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.
    Brunasso AM; Massone C
    Eur J Dermatol; 2010; 20(5):644-6. PubMed ID: 20615818
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab.
    Reddick CL; Singh MN; Chalmers RJ
    Dermatol Online J; 2010 Aug; 16(8):15. PubMed ID: 20804692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fatal epidermoid carcinoma in hidradenitis suppurativa following treatment with infliximab].
    Maalouf E; Faye O; Poli F; Cosnes A; Revuz J
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):473-4. PubMed ID: 16760840
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term infliximab for severe hidradenitis suppurativa.
    Thielen AM; Barde C; Saurat JH
    Br J Dermatol; 2006 Nov; 155(5):1105-7. PubMed ID: 17034567
    [No Abstract]   [Full Text] [Related]  

  • 27. Biologic drugs for the treatment of hidradenitis suppurativa: an evidence-based review.
    Shuja F; Chan CS; Rosen T
    Dermatol Clin; 2010 Jul; 28(3):511-21, 523-4; quiz 522-3. PubMed ID: 20510761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab.
    Schuch A; Fischer T; Boehner A; Biedermann T; Volz T
    Acta Derm Venereol; 2018 Jan; 98(1):151-152. PubMed ID: 28902952
    [No Abstract]   [Full Text] [Related]  

  • 29. Infliximab for the treatment of hidradenitis suppurativa.
    Fernández-Vozmediano JM; Armario-Hita JC
    Dermatology; 2007; 215(1):41-4. PubMed ID: 17587838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.
    Grant A; Gonzalez T; Montgomery MO; Cardenas V; Kerdel FA
    J Am Acad Dermatol; 2010 Feb; 62(2):205-17. PubMed ID: 20115947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa.
    Ghias MH; Johnston AD; Kutner AJ; Micheletti RG; Hosgood HD; Cohen SR
    J Am Acad Dermatol; 2020 May; 82(5):1094-1101. PubMed ID: 31589948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hidradenitis suppurativa treated with combination of infliximab and dapsone.
    Kozub P; Simaljakova M
    Bratisl Lek Listy; 2012; 113(5):319-23. PubMed ID: 22616594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hidradenitis suppurativa and concomitant pyoderma gangrenosum treated With infliximab.
    Groleau PF; Grossberg AL; Gaspari AA
    Cutis; 2015 Jun; 95(6):337-42. PubMed ID: 26125210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe hidradenitis suppurativa treated with infliximab infusion.
    Adams DR; Gordon KB; Devenyi AG; Ioffreda MD
    Arch Dermatol; 2003 Dec; 139(12):1540-2. PubMed ID: 14676068
    [No Abstract]   [Full Text] [Related]  

  • 35. Hidradenitis suppurativa responding to treatment with infliximab.
    Lasocki A; Sinclair R; Foley P; Saunders H
    Australas J Dermatol; 2010 Aug; 51(3):186-90. PubMed ID: 20695857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 37. Pachyonychia congenita and hidradenitis suppurativa: no response to infliximab therapy.
    Pedraz J; Peñas PF; Garcia-Diez A
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1500-1. PubMed ID: 18482325
    [No Abstract]   [Full Text] [Related]  

  • 38. Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab.
    Martínez F; Nos P; Benlloch S; Ponce J
    Inflamm Bowel Dis; 2001 Nov; 7(4):323-6. PubMed ID: 11720323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term successful adalimumab therapy in severe hidradenitis suppurativa.
    Blanco R; Martínez-Taboada VM; Villa I; González-Vela MC; Fernández-Llaca H; Agudo M; González-López MA
    Arch Dermatol; 2009 May; 145(5):580-4. PubMed ID: 19451504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate.
    De Souza A; Solomon GE; Strober BE
    Bull NYU Hosp Jt Dis; 2011; 69(2):185-7. PubMed ID: 22035400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.